Market Update

VIDEO: Paradigm Biopharma 2024 Outlook

Video thumbnail
Video Player is loading.
Current Time 0:12
Duration 4:49
Loaded: 19.31%
Stream Type LIVE
Remaining Time 4:37
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • default, selected

    Paradigm Managing Director, Paul Rennie, speaks with Stockhead and outlines the 2023 Company highlights and the potential significant milestones ahead for Paradigm in 2024.

    Disclaimer
    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.
    Publisher
    Paradigm Biopharmaceuticals